MeiraGTx Holdings (MGTX) Operating Income Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,386.07% |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 184.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 184.06% |
| Sep 30, 2025 | -15.01% |
| Jun 30, 2025 | 2.43% |
| Mar 31, 2025 | 11.07% |
| Dec 31, 2024 | 28.03% |
| Sep 30, 2024 | -22.22% |
| Jun 30, 2024 | -59.49% |
| Mar 31, 2024 | -47.27% |
| Dec 31, 2023 | -6.57% |
| Sep 30, 2023 | -43.64% |
| Jun 30, 2023 | -21.16% |
| Mar 31, 2023 | -10.53% |
| Dec 31, 2022 | -433.88% |
| Sep 30, 2022 | -1.14% |
| Jun 30, 2022 | -15.99% |
| Mar 31, 2022 | -30.42% |
| Dec 31, 2021 | 41.82% |
| Sep 30, 2021 | -167.52% |
| Jun 30, 2021 | 18.80% |
| Mar 31, 2021 | -40.52% |
| Dec 31, 2020 | -142.83% |
| Sep 30, 2020 | 22.71% |
| Jun 30, 2020 | -18.83% |
| Mar 31, 2020 | 24.22% |
| Dec 31, 2019 | 72.98% |
| Sep 30, 2019 | 26.00% |
| Jun 30, 2019 | 15.66% |
| Mar 31, 2019 | -14.63% |
| Dec 31, 2018 | -216.17% |
| Sep 30, 2018 | -68.19% |
| Jun 30, 2018 | -231.80% |